Cryo-Cell International, Inc. (FRA:ZCY)
Germany · Delayed Price · Currency is EUR 3.560
+0.160 (4.71%)
Last updated: Nov 26, 2025, 9:59 AM CET
Cryo-Cell International Income Statement
Financials in millions USD. Fiscal year is December - November.
Millions USD. Fiscal year is Dec - Nov.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Aug '25 Aug 31, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 | Nov '20 Nov 30, 2020 | 2015 - 2019 |
| 31.75 | 31.99 | 31.34 | 30.34 | 28.88 | 31.15 | Upgrade | |
Revenue Growth (YoY) | -0.29% | 2.05% | 3.32% | 5.03% | -7.26% | -2.10% | Upgrade |
Cost of Revenue | 7.28 | 7.95 | 12.13 | 8.79 | 10.15 | 10.94 | Upgrade |
Gross Profit | 24.47 | 24.04 | 19.22 | 21.54 | 18.73 | 20.21 | Upgrade |
Selling, General & Admin | 18.78 | 18.52 | 17.17 | 15.58 | 14.61 | 14.29 | Upgrade |
Research & Development | 0.6 | 1.24 | 1.17 | 0.38 | 0.05 | 0.02 | Upgrade |
Operating Expenses | 20.14 | 20.25 | 19.46 | 17.08 | 15.49 | 14.48 | Upgrade |
Operating Income | 4.33 | 3.79 | -0.25 | 4.46 | 3.24 | 5.72 | Upgrade |
Interest Expense | -2.33 | -1.86 | -1.24 | -1.08 | -1.38 | -1.54 | Upgrade |
Interest & Investment Income | - | 0.11 | 0.12 | - | - | - | Upgrade |
Other Non Operating Income (Expenses) | 0.04 | 0.01 | 0 | 0 | 0 | 0 | Upgrade |
EBT Excluding Unusual Items | 2.04 | 2.04 | -1.36 | 3.39 | 1.86 | 4.18 | Upgrade |
Gain (Loss) on Sale of Investments | -0.58 | 0.77 | 0.05 | -0.04 | -0.01 | -0.01 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | 0.41 | -0.02 | - | Upgrade |
Asset Writedown | - | - | -13.11 | - | - | - | Upgrade |
Other Unusual Items | -0 | -0 | 1.05 | -0.44 | 0.78 | 0.87 | Upgrade |
Pretax Income | 1.45 | 2.8 | -13.36 | 3.32 | 2.61 | 5.04 | Upgrade |
Income Tax Expense | 1.93 | 2.4 | -3.84 | 0.55 | 0.53 | 1.41 | Upgrade |
Net Income | -0.47 | 0.4 | -9.52 | 2.77 | 2.08 | 3.62 | Upgrade |
Net Income to Common | -0.47 | 0.4 | -9.52 | 2.77 | 2.08 | 3.62 | Upgrade |
Net Income Growth | - | - | - | 33.02% | -42.52% | 58.23% | Upgrade |
Shares Outstanding (Basic) | 8 | 8 | 8 | 8 | 8 | 8 | Upgrade |
Shares Outstanding (Diluted) | 8 | 8 | 8 | 8 | 8 | 8 | Upgrade |
Shares Change (YoY) | -1.39% | -1.54% | -1.69% | 1.46% | 2.72% | -3.24% | Upgrade |
EPS (Basic) | -0.06 | 0.05 | -1.14 | 0.33 | 0.26 | 0.48 | Upgrade |
EPS (Diluted) | -0.06 | 0.05 | -1.14 | 0.33 | 0.25 | 0.45 | Upgrade |
EPS Growth | - | - | - | 30.95% | -44.44% | 66.67% | Upgrade |
Free Cash Flow | 6.18 | 3.61 | 2.08 | -3.6 | 6.09 | 8.37 | Upgrade |
Free Cash Flow Per Share | 0.77 | 0.44 | 0.25 | -0.42 | 0.73 | 1.03 | Upgrade |
Dividend Per Share | 0.650 | 0.250 | - | - | - | - | Upgrade |
Gross Margin | 77.07% | 75.15% | 61.31% | 71.02% | 64.85% | 64.87% | Upgrade |
Operating Margin | 13.64% | 11.85% | -0.79% | 14.70% | 11.20% | 18.37% | Upgrade |
Profit Margin | -1.49% | 1.26% | -30.38% | 9.13% | 7.21% | 11.64% | Upgrade |
Free Cash Flow Margin | 19.48% | 11.28% | 6.64% | -11.85% | 21.09% | 26.86% | Upgrade |
EBITDA | 5.32 | 4.48 | 1.15 | 5.96 | 4.27 | 6.09 | Upgrade |
EBITDA Margin | 16.76% | 14.02% | 3.68% | 19.64% | 14.80% | 19.56% | Upgrade |
D&A For EBITDA | 0.99 | 0.69 | 1.4 | 1.5 | 1.04 | 0.37 | Upgrade |
EBIT | 4.33 | 3.79 | -0.25 | 4.46 | 3.24 | 5.72 | Upgrade |
EBIT Margin | 13.64% | 11.85% | -0.79% | 14.70% | 11.20% | 18.37% | Upgrade |
Effective Tax Rate | 132.61% | 85.66% | - | 16.50% | 20.21% | 28.07% | Upgrade |
Revenue as Reported | 31.75 | 31.99 | 31.34 | 30.34 | 28.88 | 31.15 | Upgrade |
Advertising Expenses | - | 1.07 | 0.95 | 0.76 | 0.84 | 0.85 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.